Top Markets
#1 Islamic Coin Islamic Coin +152.56%
#2 Bitway Bitway +51.46%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +37.70%
#4 Starpower Starpower +37.38%
#5 Pons Pons +33.82%
#6 aelf aelf +26.09%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.17%
#8 SkyAI SkyAI +19.36%
#9 Ocean Protocol Ocean Protocol +16.54%
#10 Decred Decred +14.08%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Medivir AB (publ) Medivir AB (publ)

Medivir AB (publ)

MVIR-B
Classificação em ações #29651
Medivir AB (publ) is a pharmaceutical company established in 1987 and... Medivir AB (publ) is a pharmaceutical company established in 1987 and headquartered in Huddinge, Sweden. It is dedicated to the research, development, and global commercialization of medicines, with a primary focus on oncology. The company currently markets Zoviduo (formerly Xerclear) for the treatment of labial herpes. Its robust development pipeline includes Remetinostat, targeting MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818, aimed at liver cancer; and MIV-711, being advanced for osteoarthritis. Additionally, Medivir is progressing Birinapant and IGM-8444 for various solid tumor indications. Collaborative efforts are also key to its strategy, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS CoV-2, alongside licensing agreements with Tango Therapeutics for a preclinical research program and with Ubiquigent Limited for the USP7 preclinical research program.
Preço da ação
$0.68377137
Última sincronização: 2023-05-23
Valor de mercado
$20.23M
Variação (1 dia)
-0.60%
Variação (1 ano)
0.00%
País
SE
Negociar Medivir AB (publ) (MVIR-B)

Categoria

Healthcare
Rácio P/S de Medivir AB (publ) (MVIR-B)
Rácio P/S em 2026 TTM: 0
De acordo com os relatórios financeiros mais recentes e o preço das ações da Medivir AB (publ), o rácio P/S atual (TTM) é 0. No final de 2026, o rácio P/S era 0.
Histórico do rácio P/S da Medivir AB (publ) de 2026 a 2026
Rácio P/S no final de cada ano
Ano Rácio P/S Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/S de empresas semelhantes ou concorrentes
Empresa Rácio P/S Diferença do rácio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR